Literature DB >> 24674883

Expansion of CCR4+ activated T cells is associated with memory B cell reduction in DOCK8-deficient patients.

Sonia Caracciolo1, Daniele Moratto2, Mauro Giacomelli3, Silvia Negri1, Vassilios Lougaris1, Fulvio Porta4, Giovanni Pajno5, Annamaria Salpietro5, Davide Montin6, Darrell L Dinwiddie7, Stephen F Kingsmore7, Alessandro Plebani1, Raffaele Badolato1.   

Abstract

Hyper-IgE syndrome (HIES) is a genetic disorder characterized by elevated IgE serum levels, mostly due to mutations in STAT3 or DOCK8. Despite clinical heterogeneity between the two forms of the disease, clinical manifestations may not be conclusive for diagnosis and immunological differences are still unclear. Herein, we performed a detailed characterization of the T- and B-cell compartments by flow cytometry in seven HIES patients with homozygous DOCK8 mutations and six patients presenting heterozygous STAT3 mutations. We observed that DOCK8-deficient patients showed a marked reduction of naive and recent thymic emigrant (RTE) T lymphocytes together with a relative increase of activated T cells, most of which co-expressed the chemokine receptor CCR4, a marker of Th2 polarization. Moreover, an extreme reduction of memory B cells was detected, despite a normal/increased proportion of immunoglobulin-secreting cells. These observations indicate that DOCK8-deficient patients display a distinctive immunophenotype which is characteristic of this form of HIES.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DOCK8; Hyper-IgE syndrome; Memory B cells; Recent thymic emigrants; Th2 commitment

Mesh:

Substances:

Year:  2014        PMID: 24674883     DOI: 10.1016/j.clim.2014.03.008

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  5 in total

Review 1.  Current Status of Dedicator of Cytokinesis-Associated Immunodeficiency: DOCK8 and DOCK2.

Authors:  Dimana Dimitrova; Alexandra F Freeman
Journal:  Dermatol Clin       Date:  2017-01       Impact factor: 3.478

Review 2.  Primary immunodeficiency update: Part I. Syndromes associated with eczematous dermatitis.

Authors:  Dominique C Pichard; Alexandra F Freeman; Edward W Cowen
Journal:  J Am Acad Dermatol       Date:  2015-09       Impact factor: 11.527

Review 3.  Recent Advances in DOCK8 Immunodeficiency Syndrome.

Authors:  Qian Zhang; Huie Jing; Helen C Su
Journal:  J Clin Immunol       Date:  2016-05-20       Impact factor: 8.317

4.  Susceptibility to infections, without concomitant hyper-IgE, reported in 1976, is caused by hypomorphic mutation in the phosphoglucomutase 3 (PGM3) gene.

Authors:  Karin E Lundin; Abdulrahman Hamasy; Paul Hoff Backe; Lotte N Moens; Elin Falk-Sörqvist; Katja B Elgstøen; Lars Mørkrid; Magnar Bjørås; Carl Granert; Anna-Carin Norlin; Mats Nilsson; Birger Christensson; Stephan Stenmark; C I Edvard Smith
Journal:  Clin Immunol       Date:  2015-10-19       Impact factor: 3.969

5.  CRISPR/Cas-Based Gene Editing Strategies for DOCK8 Immunodeficiency Syndrome.

Authors:  Sujan Ravendran; Sabina Sánchez Hernández; Saskia König; Rasmus O Bak
Journal:  Front Genome Ed       Date:  2022-03-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.